A
Akadeum Life Sciences
Biotech & Life Sciences · Ann Arbor, United States · Founded 2014
Working on the problem of isolating mammalian and bacterial cells from complex mixtures MoreLess
Akadeum Life Sciences, Inc. specializes in advanced cell separation technology using proprietary microbubble technology. This innovative approach allows for rapid and gentle isolation of cells without the need for magnets, making it a valuable tool for researchers in clinical labs and other biotechnical roles. Akadeum's products are designed to improve the quality and reduce the costs of cell separation processes, which are crucial in various life sciences applications, including culture, PCR, and flow cytometry. The company operates in the biotechnology market and serves a diverse range of clients, including research institutions, clinical laboratories, and corporate partners. Akadeum generates revenue through the sale of its cell isolation products and by partnering with other companies to commercialize its microbubble-based technologies. The business model focuses on continuous innovation and collaboration to enhance cell separation workflows and results.
Keywords: microbubble technology, cell isolation, biotechnology, clinical labs, research institutions, flow cytometry, PCR, cell separation, corporate partnerships, innovation.
Company overview
Akadeum Life Sciences company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- Ann Arbor, United States
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 62.8
Valuation & funding
Akadeum Life Sciences funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Aug 2026 | $0 | — | Undisclosed | ↗ |
| SERIES C✓Equity / VC | Jun 2026 | $2.1M | $8.5M | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Jun 2025 | $20M | $80M | Arboretum Ventures · Michigan Capital Network · NYBC Ventures | ↗ |
| DEBT✓Debt | Jun 2023 | $6.5M | — | Undisclosed | ↗ |
| SERIES B✓Equity / VC | May 2023 | — | — | Michigan Rise | — |
| SERIES B✓Equity / VC | Oct 2021 | Beringea · Agilent · Michigan Capital Network · Lifespan Investments | — | ||
| SERIES A✓Equity / VC | Dec 2019 | Berkeley Catalyst Fund | — | ||
| SEEDEquity / VC | Nov 2018 | Undisclosed | — | ||
| SPINOUT✓Other financing | Sep 2017 | University of Michigan | ↗ | ||
| DEBT✓Debt | Sep 2017 | Genoa Ventures | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 14 |
| 2025 | 22 |
| 2024 | 26 |
| 2023 | 30 |
| 2022 | 28 |
| 2021 | 12 |
| 2020 | 12 |
Growth signals
Akadeum Life Sciences website traffic
Latest recorded traffic for Akadeum Life Sciences is 36K monthly website visits, up 0% over the last three months. Akadeum Life Sciences's team declined 31.8% over the past year.
Comparisons
Akadeum Life Sciences compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Akadeum Life Sciences's talent
Source: Dealroom Talent Intelligence.
Investors
23 investors on Akadeum Life Sciences's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.












Global footprint
Where Akadeum Life Sciences has talent and traffic
team presence
In the news
Latest news about Akadeum Life Sciences
Recent press, funding announcements, and product moves mentioning Akadeum Life Sciences — open to read from the original sources.
Market sentiment
What the market is saying about Akadeum Life Sciences
An AI-synthesized read of the highest-engagement posts about Akadeum Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Akadeum Life Sciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.

















